Black Diamond Therapeutics Announces CEO Transition
Current Chairman of the Board and industry veteran Mark Velleca appointed CEO
Source: eagletribune.com
Davidm Epstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Davidm Epstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Davidm Epstein Today - Breaking & Trending Today
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass. and NEW YORK, Sept. 05, 2023 -- Black Diamond Therapeutics, Inc. , a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic...
Source: marketscreener.com
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Down 67.3% in July
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 1,040,000 shares, a decline of 67.3% from the July 15th total of 3,180,000 shares. Based on an average trading volume of 4,090,000 shares, the days-to-cover […]
Source: dailypolitical.com
Piper Sandler Initiates Coverage on Black Diamond Therapeutics (NASDAQ:BDTX)
Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $11.00 price objective on the stock. Other research analysts have also recently issued research reports about the stock. Wedbush upgraded shares of Black […]
Source: wkrb13.com
Black Diamond Therapeutics (NASDAQ:BDTX) Rating Increased to Buy at Stifel Nicolaus
Stifel Nicolaus upgraded shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, The Fly reports. The firm currently has $10.00 price target on the stock, up from their previous price target of $2.00. Several other brokerages have […]
Source: themarketsdaily.com